GLP-1 Drugs in Canada: Survey Reveals Impact on Appetite, Habits, and Health (2026)

An eye-opening survey reveals that a staggering 3 million Canadians are currently using GLP-1 drugs, with many more expressing interest. But here's the catch: cost is a major barrier.

The GLP-1 Revolution: Unlocking New Habits and Appetites

A recent poll conducted by Leger Healthcare has shed light on the widespread use of GLP-1 medications among Canadian adults. The survey suggests that these drugs, including popular names like Ozempic and Mounjaro, are not only impacting people's appetites but also their daily habits and spending patterns.

Unraveling the Effects: Appetite, Cravings, and Beyond

More than half of the surveyed GLP-1 users reported a decreased appetite, and an impressive 40% claimed to experience fewer food cravings. These effects have led to noticeable changes in their lifestyles. About 30% of users revealed they now dine out or order takeout less frequently, opting for healthier alternatives.

A Shift Towards Healthier Choices

The survey further highlights a shift towards healthier eating habits. Approximately a third of GLP-1 users are now purchasing more fresh fruits, vegetables, and protein-rich foods. Weight loss emerges as the primary reason for taking or considering these medications, followed closely by diabetes management. Interestingly, men were more likely than women to cite heart health as a reason for using GLP-1s.

The Cost Barrier and Insurance Coverage

While the benefits of GLP-1s are evident, cost remains a significant hurdle. Eight percent of respondents were taking prescription GLP-1 medications, and when extrapolated to the adult population, this equates to approximately 3 million Canadian adults. Additionally, a notable six percent expressed interest in GLP-1s but were deterred by the cost.

The survey also revealed that more than half of Canadians interested in GLP-1s would be influenced by insurance coverage or lower-cost generic options.

Mainstream Appeal and Impact

Melicent Lavers-Sailly, vice-president of research at Leger Healthcare, emphasizes the mainstream appeal of GLP-1s, stating, "They're no longer a niche health topic." The research underscores the impact of these medications, extending beyond prescriptions and into everyday behaviors and shopping choices.

Beyond Restaurants: A Broader Impact

GLP-1 use is not limited to dietary changes. The survey indicates that users are also altering their spending habits outside of grocery stores. Increased spending on clothes, personal care products, beauty services, and fitness activities is observed, showcasing a holistic lifestyle transformation.

Addressing Concerns: Side Effects and Cost

While cost and lack of insurance coverage are significant barriers for about half of those interested in GLP-1s, another concern arises: side effects. Approximately 36% of respondents indicated they would consider GLP-1s if the risk of side effects was lower. Common gastrointestinal side effects include nausea, vomiting, constipation, and diarrhea. However, doctors assure that most side effects are minor, with more severe complications being rare.

The Financial Burden

The survey also delves into the financial aspect, revealing that a quarter of GLP-1 users are paying for these medications out of their own pockets, with costs potentially reaching hundreds of dollars monthly. Private or public insurance plans fully cover the medication for 28% of users, while almost half have partial insurance coverage.

A Comprehensive Survey

Leger Healthcare conducted this online survey with a substantial sample size, including 1,536 Canadians and 1,012 Americans aged 18 and above. While CBC News cannot provide an exact margin of error for online surveys, for comparison, a probability sample of the Canadian sample would yield a margin of error of +/-2.49%, 19 times out of 20.

Final Thoughts and Questions

The widespread use and impact of GLP-1 drugs in Canada raise intriguing questions. Are these medications a viable solution for weight management and health improvement? How can we address the cost barrier and make these drugs more accessible? Join the discussion and share your thoughts in the comments!

GLP-1 Drugs in Canada: Survey Reveals Impact on Appetite, Habits, and Health (2026)
Top Articles
Latest Posts
Recommended Articles
Article information

Author: Golda Nolan II

Last Updated:

Views: 5656

Rating: 4.8 / 5 (58 voted)

Reviews: 89% of readers found this page helpful

Author information

Name: Golda Nolan II

Birthday: 1998-05-14

Address: Suite 369 9754 Roberts Pines, West Benitaburgh, NM 69180-7958

Phone: +522993866487

Job: Sales Executive

Hobby: Worldbuilding, Shopping, Quilting, Cooking, Homebrewing, Leather crafting, Pet

Introduction: My name is Golda Nolan II, I am a thoughtful, clever, cute, jolly, brave, powerful, splendid person who loves writing and wants to share my knowledge and understanding with you.